To the full analysis
Alteogen stock: growth
196170.KQAlteogen reported $161.8M in revenue for fiscal 2025, up 109.9% on the prior year, up 38.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
36%
per year from 2012 to 2025, per share 24.3%
Earnings (Annual rate)
42.4%
per year from 2012 to 2025, per share 30.1%
Free cash flow (Annual rate)
41.2%
per year from 2012 to 2025, per share 29.1%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2012 | |
|---|---|---|---|
| Revenue | 38.5% | 46.5% | 36.0% |
| Revenue per share | 36.8% | 43.1% | 24.3% |
| Earnings | no data | 61.0% | 42.4% |
| Earnings per share | no data | 57.3% | 30.1% |
| Free cash flow | no data | no data | 41.2% |
| Free cash flow per share | no data | no data | 29.1% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2012 | $2.97M | $1.07M | $853.63K |
| 2013 | $4.14M | $1.2M | $1.08M |
| 2014 | $5.28M | $697.96K | $882.61K |
| 2015 | $3.54M | $905.75K | −$1.24M |
| 2016 | $5.13M | −$2.69M | −$4.28M |
| 2017 | $9.07M | −$5.58M | −$3.85M |
| 2018 | $10.27M | −$5.15M | −$12.36M |
| 2019 | $21.91M | −$528.08K | $591.97K |
| 2020 | $31.8M | −$11.86M | −$3.3M |
| 2021 | $29.04M | −$4.7M | −$29.97M |
| 2022 | $21.59M | −$6.11M | −$45.29M |
| 2023 | $72.35M | −$2.53M | −$36.16M |
| 2024 | $77.1M | $46.66M | $21.44M |
| 2025 | $161.8M | $106.19M | $75.8M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₩1,334.10)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 23 Jan 2026)
- Valuation signal Fairly valued since 11 Nov 2026, previously Undervalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.